CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $1.33B, above the global median of $520.53M
- FinancialsAltman Z-Score 1.02: distress zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
379.17MUSDvs all stocks (USD)
Trailing P/E
18.96xvs Medical Care Facilities peers
Revenue (TTM)
1.33BUSDvs all stocks (USD)
Profit Margin
1.52%vs Medical Care Facilities peers
Beta
0.6140xvs all stocks
52-Week Change
-19.37%vs all stocks
Market Capitalization
379.17MUSDvs all stocks (USD)
Enterprise Value
1.18BUSDvs all stocks (USD)
Trailing P/E
18.96xvs Medical Care Facilities peers
Forward P/E
4.62xvs Medical Care Facilities peers
PEG Ratio
-0.2334xvs Medical Care Facilities peers
Price to Sales (TTM)
0.0839xvs Medical Care Facilities peers
Price to Book (MRQ)
0.7561xvs Medical Care Facilities peers
Enterprise to Revenue
0.8850xvs Medical Care Facilities peers
Enterprise to EBITDA
4.97xvs Medical Care Facilities peers
Gross Margin
36.61%vs Medical Care Facilities peers
Profit Margin
1.52%vs Medical Care Facilities peers
Operating Margin
13.15%vs Medical Care Facilities peers
Return on Assets (TTM)
5.41%vs Medical Care Facilities peers
Return on Equity (TTM)
4.59%vs Medical Care Facilities peers
Revenue (TTM)
1.33BUSDvs all stocks (USD)
Revenue per Share (TTM)
61.08USDUpdated Jul 18, 2026Quarterly Revenue Growth
13.00%vs Medical Care Facilities peers
Gross Profit (TTM)
504.92MUSDvs all stocks (USD)
Net Income (TTM)
20.26MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-81.50%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
215.56MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
68.22MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
165.60MPENFY2025 · Dec 31, 2025Revenue
4.39BPENFY2025 · Dec 31, 2025Cost of Goods Sold
2.72BPENFY2025 · Dec 31, 2025Gross Profit
1.66BPENFY2025 · Dec 31, 2025Operating Income
631.27MPEN186.55M · vs all stocks (USD)
Pre-tax Income
199.25MPENFY2025 · Dec 31, 2025Income Tax Expense
88.35MPENFY2025 · Dec 31, 2025Net Income
110.90MPENFY2025 · Dec 31, 2025EBIT
634.22MPENFY2025 · Dec 31, 2025EBITDA (Income Statement)
883.21MPENFY2025 · Dec 31, 2025Selling, General & Administrative
897.08MPENFY2025 · Dec 31, 2025Non-operating Interest Income
18.92MPENFY2025 · Dec 31, 2025Non-operating Interest Expense
434.97MPENFY2025 · Dec 31, 2025EPS (Basic)
1.32PENFY2025 · Dec 31, 2025EPS (Diluted)
1.32PENFY2025 · Dec 31, 2025Basic Shares Outstanding
74.20MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
74.20MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
110.90MPENFY2025 · Dec 31, 2025Minority Interests (P&L)
-13.29MPENFY2025 · Dec 31, 2025Operating Cash Flow
947.64MPENFY2025 · Dec 31, 2025Free Cash Flow
868.14MPENFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
335.44MPENFY2025 · Dec 31, 2025Starting Profit (CF Statement)
110.90MPENFY2025 · Dec 31, 2025Depreciation & Amortization
222.43MPENFY2025 · Dec 31, 2025Deferred Taxes (CF)
88.35MPENFY2025 · Dec 31, 2025Stock-based Compensation
11.19MPENFY2025 · Dec 31, 2025Other Non-cash Items
631.43MPENFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-81.63MPENFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-35.03MPENFY2025 · Dec 31, 2025Capital Expenditures
-79.50MPENFY2025 · Dec 31, 2025Net Intangibles (CF)
-58.67MPENFY2025 · Dec 31, 2025Net Acquisitions
0.00PENFY2025 · Dec 31, 2025Sale of Investments
75.69MPENFY2025 · Dec 31, 2025Other Investing Activity
-21.14MPENFY2025 · Dec 31, 2025Net Investing Cash Flow
-24.96MPENFY2025 · Dec 31, 2025Long-term Debt Issuance
4.10BPENFY2025 · Dec 31, 2025Long-term Debt Payments
-4.07BPENFY2025 · Dec 31, 2025Common Dividends Paid
0.00PENFY2025 · Dec 31, 2025Other Financing Charges
-110.21MPENFY2025 · Dec 31, 2025Net Financing Cash Flow
-78.83MPENFY2025 · Dec 31, 2025Shares Outstanding
74.06MSharesUpdated Jul 18, 2026Float Shares
27.53MSharesUpdated Jul 18, 2026Shares Short
705.55KSharesUpdated Jul 18, 2026Short Ratio
2.24daysvs all stocks
Short % of Shares Outstanding
3.37%vs all stocks
% Held by Insiders
8.76%vs all stocks
% Held by Institutions
77.32%vs all stocks
Total Cash (MRQ)
126.41MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.78USDUpdated Jul 18, 2026Total Debt (MRQ)
1.14BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
2.02xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.09xvs Medical Care Facilities peers
Book Value per Share (MRQ)
6.77USDUpdated Jul 18, 2026Total Assets
7.30BPEN2.16B · vs all stocks (USD)
Total Current Assets
1.84BPENFY2025 · Dec 31, 2025Total Liabilities
5.53BPENFY2025 · Dec 31, 2025Total Non-current Assets
5.45BPENFY2025 · Dec 31, 2025Total Non-current Liabilities
3.86BPENFY2025 · Dec 31, 2025Total Current Liabilities
1.67BPENFY2025 · Dec 31, 2025Cash
274.96MPENFY2025 · Dec 31, 2025Cash Equivalents
60.48MPENFY2025 · Dec 31, 2025Cash & Cash Equivalents
335.44MPENFY2025 · Dec 31, 2025Other Short-term Investments
30.24MPENFY2025 · Dec 31, 2025Accounts Receivable
1.04BPENFY2025 · Dec 31, 2025Inventory
164.80MPENFY2025 · Dec 31, 2025Accounts Payable
1.05BPENFY2025 · Dec 31, 2025Short-term Debt
345.62MPENFY2025 · Dec 31, 2025Deferred Revenue
9.54MPENFY2025 · Dec 31, 2025Other Current Liabilities
42.25MPENFY2025 · Dec 31, 2025Long-term Debt
3.31BPENFY2025 · Dec 31, 2025Common Stock (Book)
17.39MPENFY2025 · Dec 31, 2025Retained Earnings
-192.62MPENFY2025 · Dec 31, 2025Total Shareholders' Equity
1.77BPEN521.98M · vs all stocks (USD)
52-Week Low
4.09USDUpdated Jul 18, 202652-Week High
6.85USDUpdated Jul 18, 202652-Week Change
-19.37%vs all stocks
Beta
0.6140xvs all stocks
50-Day MA
4.88USDUpdated Jul 18, 2026200-Day MA
5.21USDUpdated Jul 18, 2026Avg 10-Day Volume
151.89KSharesUpdated Jul 18, 2026Avg 30-Day Volume
246.53KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
0.2700USDUpdated Jul 18, 2026Other Income / Expense
23.92MPENFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.02: distress zoneCritical
Altman Z-Score: 1.02
High earnings qualityNotable
Earnings Quality Score: 3.50
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $1.33B, above the global median of $520.53MNotable
Revenue (USD): 1,332,475,820Global Median: 520,528,949.311
Levered free cash flow is $68.22M, above the global median of $16.24MNotable
Levered free cash flow (USD): 68,222,407Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Liaoning He Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Universal Vision Biotechnology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionInterface
Q & M Dental Group (Singapore) Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Solasto Corporation
Tier 1RuleThroughput-Bound ConversionFlowProduction
Praram 9 Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionFlowProduction
Hospital Mater Dei S.A.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Community Health Systems, Inc.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Charming Medical Limited
Tier 1RuleThroughput-Bound ConversionProductionInterface
Sarana Meditama Metropolitan Tbk
Tier 1RuleThroughput-Bound ConversionFlowProduction
C-MER Medical Holdings Ltd.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Verra Mobility Corporation
5 interpretationsElevated Leverage on Three DenominatorsReceivables Heavy and GrowingCash-Flow Ratios ElevatedDrawdown With FCF And Cash BackingWithin or Near the Altman Distress Zone
Seika Corporation
4 interpretationsFCF Ratios ElevatedReceivables Heavy and GrowingCash-Flow Ratios ElevatedWithin or Near the Altman Distress Zone
Linzhou Heavy Machinery Co., Ltd.
4 interpretationsElevated Leverage on Three DenominatorsFCF Ratios ElevatedCash-Flow Ratios ElevatedWithin or Near the Altman Distress Zone